<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03843879</url>
  </required_header>
  <id_info>
    <org_study_id>IRB18-109</org_study_id>
    <nct_id>NCT03843879</nct_id>
  </id_info>
  <brief_title>TAP Blocks vs. IV Lidocaine for Kidney Transplants</brief_title>
  <official_title>A Comparison of Transversus Abdominis Plane Blocks Versus Continuous Intravenous Lidocaine for Kidney Transplant Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Benaroya Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Benaroya Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare continuous intravenous lidocaine against single-injection transversus
      abdominis plane (TAP) block as a modality for postoperative analgesia in kidney transplant
      surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a non-inferiority trial designed to assess the analgesic efficacy of an
      intravenous (IV) lidocaine infusion against single-injection transversus abdominis plane
      (TAP) block in patients undergoing kidney transplant surgery. The investigators propose a
      study of 124 subjects randomized into two groups. The control group will receive a TAP block.
      The study group will receive a continuous IV lidocaine infusion. The investigators
      hypothesize that there will be no statistically significant difference in postoperative
      opioid consumption between the two groups in the first 24 hours.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2019</start_date>
  <completion_date type="Anticipated">September 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2021</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Opioid Consumption</measure>
    <time_frame>0-24 Hours</time_frame>
    <description>Total opioid utilization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Scores</measure>
    <time_frame>0-48 Hours</time_frame>
    <description>Numerical Rating Scale Pain Scores (Range: 0-10, where 0 is no pain and 10 is the worst pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid Consumption</measure>
    <time_frame>24-48 Hours</time_frame>
    <description>Total opioid utilization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid-Related Adverse Events</measure>
    <time_frame>0-48 Hours</time_frame>
    <description>Nausea, Vomiting, Pruritis, Respiratory Depression, Constipation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Block/Infusion-Related Adverse Events</measure>
    <time_frame>0-48 Hours</time_frame>
    <description>Local Anesthetic Systemic Toxicity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid Usage</measure>
    <time_frame>30 days from discharge</time_frame>
    <description>Use of prescribed opioids</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">124</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>TAP Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single-injection transversus abdominis plane block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IV Lidocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continuous intravenous lidocaine infusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transversus Abdominis Plane Block</intervention_name>
    <description>Single-injection transversus abdominis plane block with 30 mL of 0.25% Bupivacaine with 1:400,000 epinephrine</description>
    <arm_group_label>TAP Block</arm_group_label>
    <other_name>TAP Block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous Lidocaine</intervention_name>
    <description>Continuous intravenous lidocaine infusion</description>
    <arm_group_label>IV Lidocaine</arm_group_label>
    <other_name>Continuous intravenous lidocaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Kidney transplant recipient

          -  &gt;18 years old

          -  Consent to participate

        Exclusion Criteria:

          -  &lt;18 years old

          -  Refusal to participate

          -  Chronic opioid use

          -  Seizure disorder

          -  Allergy to local anesthestics

          -  Severe hepatic disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neil A Hanson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Virginia Mason Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Neil A Hanson, MD</last_name>
    <phone>206-223-6980</phone>
    <email>neil.hanson@virginiamason.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Wyndam M Strodtbeck, MD</last_name>
    <phone>206-223-6980</phone>
    <email>wyndam.strodtbeck@virginiamason.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Virginia Mason Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neil A Hanson, MD</last_name>
      <email>neil.hanson@virginiamason.org</email>
    </contact>
    <contact_backup>
      <last_name>Wyndam M Strodtbeck, MD</last_name>
      <email>wyndam.strodtbeck@virginiamason.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>February 14, 2019</study_first_submitted>
  <study_first_submitted_qc>February 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 18, 2019</study_first_posted>
  <last_update_submitted>July 15, 2019</last_update_submitted>
  <last_update_submitted_qc>July 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Benaroya Research Institute</investigator_affiliation>
    <investigator_full_name>Neil Hanson</investigator_full_name>
    <investigator_title>Anesthesiologist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

